SNX27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.07969999607604E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.71808999999135E-05 |
Normal-vs-Stage2 |
1.73793000000089E-05 |
Normal-vs-Stage3 |
9.73350289257269E-11 |
Normal-vs-Stage4 |
1.58700053098926E-10 |
Stage1-vs-Stage2 |
2.584400E-01 |
Stage1-vs-Stage3 |
7.845800E-04 |
Stage1-vs-Stage4 |
9.595600E-04 |
Stage2-vs-Stage3 |
2.145800E-01 |
Stage2-vs-Stage4 |
1.694230E-01 |
Stage3-vs-Stage4 |
8.251600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.51009996016438E-09 |
Normal-vs-AfricanAmerican |
1.08990000025067E-07 |
Normal-vs-Asian |
9.910800E-01 |
Caucasian-vs-AfricanAmerican |
1.567940E-02 |
Caucasian-vs-Asian |
6.348400E-02 |
AfricanAmerican-vs-Asian |
2.726100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.57169952000424E-10 |
Normal-vs-Female |
3.61159999999749E-05 |
Male-vs-Female |
1.566230E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.10310000001057E-06 |
Normal-vs-Age(41-60Yrs) |
2.91550000031116E-07 |
Normal-vs-Age(61-80Yrs) |
4.65429994545019E-09 |
Normal-vs-Age(81-100Yrs) |
5.193700E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.538610E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.817200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.723400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.492580E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.776800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.371600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.749600E-01 |
Normal-vs-Grade 2 |
2.16789999996081E-06 |
Normal-vs-Grade 3 |
2.73709999110139E-09 |
Normal-vs-Grade 4 |
1.64157576421076E-12 |
Grade 1-vs-Grade 2 |
1.640820E-01 |
Grade 1-vs-Grade 3 |
8.903600E-02 |
Grade 1-vs-Grade 4 |
2.337600E-02 |
Grade 2-vs-Grade 3 |
7.631800E-02 |
Grade 2-vs-Grade 4 |
1.91419999995279E-06 |
Grade 3-vs-Grade 4 |
1.758360E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.216500E-02 |
Normal-vs-ccB subtype |
6.36857233615729E-12 |
ccA subtype-vs-ccB subtype |
2.24680052340887E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.53260000024247E-07 |
Normal-vs-N1 |
4.819400E-03 |
N0-vs-N1 |
9.136000E-01 |
|
|